Product Images Xaracoll

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Xaracoll NDC 51715-100 by Innocoll Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pouch - image0001v1

pouch - image0001v1

This is a description of a pharmaceutical product called "xaraccll" which is a bupivacaine HCI implant intended for surgical use only. Each pouch contains 3x100 mg sterile implants with lot and expiration date information. The dosage is provided as 3 implants equivalent to 300mg bupivacaine HCI. The storage conditions are mentioned and a warning is given not to use if the packaging is damaged. The product is distributed by Innocoll Pharmaceuticals Ltd. in Ireland. The text also includes some non-readable characters.*

carton - image0002v1

carton - image0002v1

The text appears to be a description of a medication called Xaracoll. This medication is available in a sterile implant form containing 100mg of Bupivacaine HCl per implant, with each pouch containing three implants. The recommended dosage is three implants, equivalent to 300mg of Bupivacaine HCl. The medication is for surgical implantation and is stored at a temperature between 20°C to 25°C. The text also includes dosage instructions and storage guidelines. The medication is distributed by Innocoll Pharmaceuticals Ltd.*

carton - image0003v1

carton - image0003v1

This is a product description for Xaracoll, a bupivacaine hydrochloride implant used for pain relief. The implant comes in single-use cartons, with each carton containing one pouch that has three 100 mg sterile implants. The recommended dosage is three implants equivalent to 300 mg of bupivacaine HCl. The product has a storage temperature requirement of 20-25°C and must not be used if the pouch or blister packaging is damaged. The text also includes dosage information, warnings, a reference to the National Drug Code (NDC) 51715-100-10, and instructions for dispensing.*

carton - image0004v1

carton - image0004v1

Xaracoll is a surgical implant that contains bupivacaine HCI, used to manage postoperative pain. Each implant contains 100mg of bupivacaine HCI, equivalent to 88.8mg of bupivacaine. The dosage recommended is three implants equivalent to 300mg of bupivacaine HCI. The product comes in 4 single-use cartons, each containing one pouch containing three sterile implants. The pharmacist should dispense it as a single-use carton with one pouch. It is essential not to use it if the pouch or bister packaging is damaged. Xaracoll should be stored at 20°C to 25°C with excursions permitted between 15°C and 30°C (between 59°F and 86°F). Xaracoll is distributed by Innocoll Pharmaceuticals Ltd in Athlone, Ireland.*

Structural Formula - structureformula

Structural Formula - structureformula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.